Ramalingam, Nagendran http://orcid.org/0000-0002-9459-3593
Jin, Shan-Xue
Moors, Tim E.
Fonseca-Ornelas, Luis http://orcid.org/0000-0001-7810-5564
Shimanaka, Kazuma
Lei, Shi
Cam, Hugh P.
Watson, Aurelia Hays
Brontesi, Lisa
Ding, Lai
Hacibaloglu, Dinc Yasat
Jiang, Haiyang http://orcid.org/0000-0003-0192-3889
Choi, Se Joon
Kanter, Ellen
Liu, Lei http://orcid.org/0000-0002-4604-4629
Bartels, Tim
Nuber, Silke
Sulzer, David http://orcid.org/0000-0001-7632-0439
Mosharov, Eugene V. http://orcid.org/0000-0002-0229-7114
Chen, Weisheng V.
Li, Shaomin http://orcid.org/0000-0001-9451-2151
Selkoe, Dennis J. http://orcid.org/0000-0001-8846-9767
Dettmer, Ulf http://orcid.org/0000-0001-6676-0107
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS121826, NS099328, NS109510, NS09435, NS083845)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Brigham and Women’s Hospital
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
JPB Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Article History
Received: 12 July 2022
Accepted: 22 December 2022
First Online: 16 January 2023
Competing interests
: D.J.S. is a director and consultant to Prothena Biosciences. W.V.C. is the CEO of Leveragen. The other authors declare no competing financial or non-financial interests.